Drossapharm AG ensures continuous access to critical production and quality data by creating a two-node hyperconverged setup
Drossapharm AG ensures continuous access to critical production and quality data by creating a two-node hyperconverged setup
1 PagesDrossapharm AG, a Swiss pharmaceutical company specializing in the development and production of Swiss-made medicines, needed a more resilient IT infrastructure to support continuous access to critical production and quality data. Before deploying StarWind HCI Appliance (HCA), the company relied on standalone bare-metal servers functioning as individual Hyper-V hosts without SAN capabilities, creating single points of failure and limiting system availability. By implementing a two-node hyperconverged setup with StarWind HCA, Drossapharm consolidated compute and storage into a highly available platform with improved fault tolerance and simplified management. The solution enabled continuous access to mission-critical applications and data, enhanced infrastructure reliability, and strengthene
